Healthcare entity

Ibogaine

Technology

funding is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Psilocybin, the most common co-covered peer. The tracked stories average 2 original sources each. Ibogaine appears in 1 tracked Healthcare story from February 21, 2026.

Last mentioned: Feb 21, 2026

RSS updates
Share

Entity pulse

Recent coverage · Ibogaine

1 story
5 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Ibogaine

funding is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Psilocybin, the most common co-covered peer. The tracked stories average 2 original sources each. Ibogaine appears in 1 tracked Healthcare story from February 21, 2026.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 16 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Ibogaine. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Valuation Period

    Expected timeframe for determining the fair market value of the equity investment.

  2. Option Exercised

    PsyLabs officially triggers the put option, requiring an equity investment from PBM.

  3. Put Option Established

    Psyence BioMed and PsyLabs enter into a strategic put option agreement.

Stories mentioning Ibogaine 1

Ibogaine is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.